Venetoclax plus bendamustine-rituximab or bendamustine-obinutuzumab in chronic lymphocytic leukemia: final results of a phase 1b study (GO28440)
Venetoclax 加苯达莫司汀-利妥昔单抗或苯达莫司汀-obinutuzumab 治疗慢性淋巴细胞白血病：1b 期研究的最终结果 (GO28440)
期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2020.261107
Stilgenbauer, Stephan; Morschhauser, Franck; Wendtner, Clemens-Martin; Cartron, Guillaume; Hallek, Michael; Eichhorst, Barbara; Kozloff, Mark F; Giever, Thomas; Lozanski, Gerard; Jiang, Yanwen; Huang, Huang; Pignataro, Daniela Soriano; Schary, William; Humphrey, Kathryn; Mobasher, Mehrdad; Salles, Gilles
